1. Home
  2. GNLX vs INVE Comparison

GNLX vs INVE Comparison

Compare GNLX & INVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNLX
    SELLHOLDBUYas of 7 hours ago
  • INVE
    SELLHOLDBUYas of 7 hours ago
  • Stock Information
  • Founded
  • GNLX 2001
  • INVE 1990
  • Country
  • GNLX United States
  • INVE United States
  • Employees
  • GNLX N/A
  • INVE N/A
  • Industry
  • GNLX Biotechnology: Pharmaceutical Preparations
  • INVE Computer peripheral equipment
  • Sector
  • GNLX Health Care
  • INVE Technology
  • Exchange
  • GNLX Nasdaq
  • INVE Nasdaq
  • Market Cap
  • GNLX 184.4M
  • INVE 82.2M
  • IPO Year
  • GNLX 2023
  • INVE 1997
  • Fundamental
  • Price
  • GNLX $3.58
  • INVE $3.24
  • Analyst Decision
  • GNLX Strong Buy
  • INVE Strong Buy
  • Analyst Count
  • GNLX 4
  • INVE 3
  • Target Price
  • GNLX $18.25
  • INVE $6.83
  • AVG Volume (30 Days)
  • GNLX 174.5K
  • INVE 79.1K
  • Earning Date
  • GNLX 03-31-2025
  • INVE 03-05-2025
  • Dividend Yield
  • GNLX N/A
  • INVE N/A
  • EPS Growth
  • GNLX N/A
  • INVE N/A
  • EPS
  • GNLX N/A
  • INVE 3.05
  • Revenue
  • GNLX $8,000.00
  • INVE $26,628,000.00
  • Revenue This Year
  • GNLX N/A
  • INVE N/A
  • Revenue Next Year
  • GNLX N/A
  • INVE $40.32
  • P/E Ratio
  • GNLX N/A
  • INVE $1.11
  • Revenue Growth
  • GNLX N/A
  • INVE N/A
  • 52 Week Low
  • GNLX $1.60
  • INVE $2.95
  • 52 Week High
  • GNLX $7.04
  • INVE $8.52
  • Technical
  • Relative Strength Index (RSI)
  • GNLX 42.56
  • INVE 41.08
  • Support Level
  • GNLX $3.51
  • INVE $3.17
  • Resistance Level
  • GNLX $4.37
  • INVE $3.52
  • Average True Range (ATR)
  • GNLX 0.44
  • INVE 0.27
  • MACD
  • GNLX -0.13
  • INVE -0.03
  • Stochastic Oscillator
  • GNLX 12.82
  • INVE 20.00

Stock Price Comparison Chart: GNLX vs INVE

GNLX
INVE
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober20250510152025303540GNLX VS INVE

About GNLX Genelux Corporation

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.

About INVE Identiv Inc.

Identiv Inc is a security technology company. It secures and manages access to physical places, things, and information. The company has two reportable segments namely the Premises segment which includes solutions to address the premises security market for government and enterprise, including access control, video surveillance, analytics, customer experience, and other applications. Its Identity segment includes products and solutions enabling secure access to information serving the logical access and cyber security market and protecting assets and objects in the IoT with RFID. Geographically, it generates maximum revenue from the Americas and also has a presence in Europe and the Middle East, and Asia-Pacific. The company derives the majority of revenue from the Identity segment.

Share on Social Networks:

By browsing this website, you accept our Privacy Policy & Terms of Use